Abiopharma

Annual General Meeting :: Voluntary

Annual Report FY2025

Mandatory Cash Dividend / Distribution (FY2025)

Notice of Annual General Meeting (FY2025)

NOVONIX US$103 Million 48C Tax Credits Certified for Synthetic Graphite Facility

ResMed Inc. Daily Stock Update

Texas Capital Bancshares, Inc. Announces Date for Q1 2026 Operating Results

Extendicare Announces $450 Million Inaugural Offering of Investment Grade Senior Unsecured Notes

Retractable Technologies, Inc. Announces Workforce Reduction

ImmunityBio, Inc. (IBRX) Facing Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman